Murielle Thinard-McLane

As CEO, Murielle brings her expertise in healthcare and business strategy to revolutionize point of care molecular diagnostics.

Most recently she was the COO of Genome Medical, a genetics telehealth practice where she was responsible for product, engineering, business development, sales and marketing. Prior to that, she was an Executive in Residence for GE Healthcare Ventures. Previously, she spent 7 years as an executive at McKesson and held a variety of positions at Novartis, Genentech, and UnitedHealth/OptumHealth.

Murielle has an MBA in Healthcare Management from the Wharton School and a Master’s degree in Finance from Université Jean Moulin, Lyon, France.

In her spare time, she serves on the executive council on pharmaceuticals and digital health of Springboard Enterprises, a highly-vetted expert network of innovators, investors and influencers dedicated to building high-growth technology-oriented companies led by women.